The PSA is looking for a new chief executive officer after Dr Lance Emerson announced his resignation today
Dr Emerson, who has been CEO of the peak body for three and a half years, will leave the organisation in January 2018.
PSA National President Dr Shane Jackson applauded Dr Emerson’s achievements and “strong leadership”.
“I congratulate and thank Dr Emerson for his effective and strategic leadership of PSA to ensure all pharmacists are well represented and engaged across Australia,” Dr Jackson said.
“His dedication and service to the profession – and engagement with key stakeholders – has been admirable and I’m sure our members would agree he has taken PSA to the next level in terms of advocacy, professional development and practice support.”
Dr Emerson’s achievements include transforming PSA from six separate entities into a unified entity for advocacy, training and membership, and securing recognition as the peak organisation for pharmacists via peak Health Professional Association funding from the Federal Government.
“Dr Emerson has also been instrumental in increasing the public recognition of the role of pharmacists and PSA through a strong, proactive mainstream media and communications strategy,” Dr Jackson said.
“Dr Emerson has also championed key reforms and sector dialogue on issues including pharmacist wages, Early Career Pharmacists, new career pathways, innovative/evidence-based pharmacist services, community pharmacy reforms, women in pharmacy and equality.”
Dr Emerson said that he was proud to have led PSA and enjoyed the challenge of developing it into a stronger, more sustainable body, improving member services and aligning efforts across Australia.
“I sincerely thank PSA’s National Board, Branch Committees, Executive team and the dedicated and competent PSA staff – as well as all PSA members and supporters.”
A recruitment process for Dr Emerson’s replacement is underway.
The Executive Director of the Pharmacy Guild, David Quilty, said that the Guild acknowledges Dr Emerson’s strong leadership of the PSA.
“During his tenure as CEO of the PSA, Dr Emerson has been an effective advocate for the profession with a strong focus on enhancing the role of pharmacists in medication management and primary care,” Mr Quilty said.
“I have appreciated the opportunity to work with Lance and wish him the very best for the future.
“The Guild will continue working collaboratively with the PSA under any incoming CEO in the interests of patients, community pharmacies and the pharmacist profession.”